Showing results (301-310 of 435) with videos related to
Sort By:
Pageof 44
Frontiers in Oncology|January 7, 2022
MRI Radiomics in Prostate Cancer: A Reliability StudyFabrizio Urraro, Valerio Nardone, Alfonso Reginelli, et al.Chemmedchem|February 8, 2014
Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cellsAlessia Lenoci, Stefano Tomassi, Mariarosaria Conte, et al.Chemmedchem|October 25, 2013
Carprofen analogues as sirtuin inhibitors: enzyme and cellular studiesPaolo Mellini, Vincenzo Carafa, Barbara Di Rienzo, et al.Frontiers in Oncology|February 15, 2021
Searching for a Putative Mechanism of RIZ2 Tumor-Promoting Function in Cancer ModelsMonica Rienzo, Anna Sorrentino, Erika Di Zazzo, et al.Molecular Pharmacology|August 2, 2007
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemiaAntonello Mai, Katija Jelicic, Dante Rotili, et al.Journal of Medicinal Chemistry|June 28, 2014
1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cellsSergio Valente, Daniela Trisciuoglio, Teresa De Luca, et al.Journal of Molecular Endocrinology|July 20, 2010
HDACs class II-selective inhibition alters nuclear receptor-dependent differentiationAngela Nebbioso, Carmela Dell'Aversana, Anne Bugge, et al.Plos One|December 19, 2013
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or bIlaria Lepore, Carmela Dell'Aversana, Maxim Pilyugin, et al.Physical Review Letters|October 26, 2005
Controlling two-center interference in molecular high harmonic generationC Vozzi, F Calegari, E Benedetti, et al.Biochimie|June 20, 2012
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cellsSergio Valente, Ilaria Lepore, Carmela Dell'Aversana, et al.Pageof 44